Kenneth Cohen Insider Profile
4 Followers
Kenneth Cohen, former Director at MabVax Therapeutics Holdings, holds 26.81K shares in MabVax Therapeutics Holdings (Ticker: MBVXQ), holds 120.83K shares in Somaxon Pharmaceuticals (Ticker: SOMX), holds 69.78K shares in DMK Pharmaceuticals (Ticker: DMKPQ).
Kenneth Cohen's Trading History
| MBVXQMabVax Therapeutics Holdings | Jan 24, 2018 | ― | Uninformative Sell | 30.29K | $616.58 | |
| DMKPQDMK Pharmaceuticals | Mar 07, 2013 | ― | Uninformative Buy | ― | ― | |
| SOMXSomaxon Pharmaceuticals | ― | ― | ― | ― |
You May Also Like
Kenneth Cohen insider profile FAQ
What is the percentage of profitable transactions made by Kenneth Cohen?
The percentage of profitable transactions made by Kenneth Cohen is 0%.
What is the average return per transaction made by Kenneth Cohen?
The average return per transaction made by Kenneth Cohen is -70.10%.
What stocks does Kenneth Cohen hold?
Kenneth Cohen holds: MBVXQ, SOMX, DMKPQ stocks.
What was Kenneth Cohen’s latest transaction?
Kenneth Cohen’s latest transaction was an Uninformative Sell of $30.29K.
What was Kenneth Cohen's most profitable transaction?
Kenneth Cohen’s most profitable transaction was an Informative Buy of MBVXQ stock on December 17, 2014. The return on the trade was -67.40%.
What is Kenneth Cohen's role in MabVax Therapeutics Holdings?
Kenneth Cohen's role in MabVax Therapeutics Holdings is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
